Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1992 1
1995 2
1996 3
1997 2
1998 5
1999 1
2000 3
2001 3
2002 1
2003 3
2004 3
2006 5
2007 4
2008 4
2009 5
2010 7
2011 11
2012 8
2013 7
2014 5
2015 10
2016 8
2017 17
2018 11
2019 9
2020 10
2021 8
2022 13
2023 15
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Oral Tranexamic Acid for the Treatment of Melasma: A Review.
Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Bala HR, et al. Among authors: pandya ag. Dermatol Surg. 2018 Jun;44(6):814-825. doi: 10.1097/DSS.0000000000001518. Dermatol Surg. 2018. PMID: 29677015 Review.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. Among authors: pandya ag. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792
Melasma Treatment: An Evidence-Based Review.
McKesey J, Tovar-Garza A, Pandya AG. McKesey J, et al. Among authors: pandya ag. Am J Clin Dermatol. 2020 Apr;21(2):173-225. doi: 10.1007/s40257-019-00488-w. Am J Clin Dermatol. 2020. PMID: 31802394
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.
Ezzedine K, Peeva E, Yamaguchi Y, Cox LA, Banerjee A, Han G, Hamzavi I, Ganesan AK, Picardo M, Thaçi D, Harris JE, Bae JM, Tsukamoto K, Sinclair R, Pandya AG, Sloan A, Yu D, Gandhi K, Vincent MS, King B. Ezzedine K, et al. Among authors: pandya ag. J Am Acad Dermatol. 2023 Feb;88(2):395-403. doi: 10.1016/j.jaad.2022.11.005. Epub 2022 Nov 9. J Am Acad Dermatol. 2023. PMID: 36370907 Free article. Clinical Trial.
New discoveries in the pathogenesis and classification of vitiligo.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group. Rodrigues M, et al. Among authors: pandya ag. J Am Acad Dermatol. 2017 Jul;77(1):1-13. doi: 10.1016/j.jaad.2016.10.048. J Am Acad Dermatol. 2017. PMID: 28619550 Review.
Lichen planus pigmentosus and its variants: review and update.
Robles-Méndez JC, Rizo-Frías P, Herz-Ruelas ME, Pandya AG, Ocampo Candiani J. Robles-Méndez JC, et al. Among authors: pandya ag. Int J Dermatol. 2018 May;57(5):505-514. doi: 10.1111/ijd.13806. Epub 2017 Oct 26. Int J Dermatol. 2018. PMID: 29076159 Review.
Psychosocial Effects of Vitiligo: A Systematic Literature Review.
Ezzedine K, Eleftheriadou V, Jones H, Bibeau K, Kuo FI, Sturm D, Pandya AG. Ezzedine K, et al. Among authors: pandya ag. Am J Clin Dermatol. 2021 Nov;22(6):757-774. doi: 10.1007/s40257-021-00631-6. Epub 2021 Sep 23. Am J Clin Dermatol. 2021. PMID: 34554406 Free PMC article.
scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function.
Gellatly KJ, Strassner JP, Essien K, Refat MA, Murphy RL, Coffin-Schmitt A, Pandya AG, Tovar-Garza A, Frisoli ML, Fan X, Ding X, Kim EE, Abbas Z, McDonel P, Garber M, Harris JE. Gellatly KJ, et al. Among authors: pandya ag. Sci Transl Med. 2021 Sep 8;13(610):eabd8995. doi: 10.1126/scitranslmed.abd8995. Epub 2021 Sep 8. Sci Transl Med. 2021. PMID: 34516831 Free PMC article.
Efficacy of ruxolitinib cream in vitiligo by patient characteristics and affected body areas: Descriptive subgroup analyses from a phase 2, randomized, double-blind trial.
Hamzavi I, Rosmarin D, Harris JE, Pandya AG, Lebwohl M, Gottlieb AB, Butler K, Kuo FI, Sun K, Grimes P. Hamzavi I, et al. Among authors: pandya ag. J Am Acad Dermatol. 2022 Jun;86(6):1398-1401. doi: 10.1016/j.jaad.2021.05.047. Epub 2021 Jun 2. J Am Acad Dermatol. 2022. PMID: 34089797 Free article. Clinical Trial. No abstract available.
161 results